-
DiscoveryInnovating on a trusted class of antibiotics to attack superbugs
A new compound aims to attack dangerous antibiotic-resistant bacteria.
Discovery -
DiscoveryWomen in Science: Cathryn Clary
Our Global Head of Patient Affairs and Policy shares why it’s critical to engage patients throughout the drug development process.
Discovery -
From Our LabsMinion challenges assumptions about the genome
A diminutive protein prompts a closer look at DNA dark matter.
From Our Labs -
DiscoveryGoing global to meet local needs in China
Marc Pelletier traveled from Cambridge, MA to Shanghai, China, to launch new lines of research for the treatment of cancers that are common in China.
Discovery -
Patient PerspectivesChoosing the right care
Melanoma survivor T.J. Sharpe shares why patients should know their treatment options.
Patient Perspectives -
DiscoveryWomen in Science: Renee Rodgers
Discovery -
Access to HealthcareNovartis invites scrutiny of effort to improve access to medicine
Public health expert Richard Laing discusses how independent measurement of access programs can help ensure their success
Access to Healthcare -
DiscoveryTaking clinical trials to the next level through technology
Learn how Novartis is using technology to improve the oncology clinical trial process.
Discovery -
DiscoverySaving tumor suppressors from the shredder
Novartis opens up a path of research to protect proteins that guard against cancer.
Discovery -
DiscoveryWomen in Science: Medy Attalla
Discovery -
DiscoveryThe specter of malaria that resists treatment
Great progress has been made against malaria, but signs of resistance are becoming a rising concern
Discovery -
DiscoveryLoss of friend to liver cancer sharpens focus on experimental therapy
A Novartis experimental drug in clinical trial aims to block liver cancer growth
Discovery